# US 2013/0157375 A1 · Compound

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157375 A1
- Document ID: US20130157375A1
- Status: Published application
- Kind: A1
- Application number: 13/643,198
- Filed: 2011-04-27
- Published: 2013-06-20
- Earliest claimed: 2010-04-29
- Assignees: London School of Hygiene and Tropical Medicine; King's College London
- Inventors: Robert Hider; Yongmin Ma; Ulrich Schaible; Maria Podinovskaia
- Web page: https://patentgrep.com/patent/US20130157375A1

## CPC

- C07D 213/68: attached in position 4
- C07D 213/69: Two or more oxygen atoms
- C07D 309/40: Oxygen atoms attached in positions 3 and 4, e.g. maltol
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 405/12: linked by a chain containing hetero atoms as chain links
- C07D 405/14: containing three or more hetero rings
- G01N 33/90: involving iron binding capacity of blood
- C07B 2200/11: Compounds covalently bound to a solid support
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

In one aspect, there is provided a fluorescent iron-binding compound bound to a solid phase. Also provided is a method for detecting non-transferrin bound iron in a sample, comprising contacting the sample with a fluorescent iron-binding compound bound to a solid phase and detecting a fluorescent signal derived from the fluorescent iron-binding compound bound to the solid phase, wherein the fluorescent signal is indicative of non-transferrin bound iron levels in the sample. Further provided is use of a fluorescent iron-binding compound bound to a solid phase to detect non-transferrin bound iron in a sample.

## Claims

### Claim 1

A fluorescent iron-binding compound bound to a solid phase.

### Claim 2 (depends on 1)

The compound according to claim 1, comprising an iron-binding moiety and a fluorophore, wherein a fluorescent signal generated by the fluorophore is modulated in response to binding of iron to the iron-binding moiety.

### Claim 3 (depends on 1)

The compound according to claim 1, comprising a group of formula I:
wherein:
R1, R2, R3 and R4 are each independently selected from hydrogen, hydroxyl and C1-C5 alkyl, e.g. methyl, provided that at least one of R1 and R4 is hydroxyl;
R5 comprises a linkage to a solid phase; and
R6 comprises a fluorophore.

### Claim 4 (depends on 1)

The compound according to claim 1, comprising a fluorophore selected from the group consisting of fluorescein, rhodamine, dansyl, phycoerythrin, phycocyanin, allophycocyanin, o-phthaldehyde, cascade blue, coumarin, naphthalenes, pyrenes, pyridyloxazole derivatives and fluorescamine.

### Claim 5 (depends on 4)

The compound according to claim 4, wherein the fluorophore comprises fluorescein.

### Claim 6 (depends on 1)

The compound according to claim 1, which is covalently bound to the solid phase.

### Claim 7 (depends on 1)

The compound according to claim 1, which is linked to a solid phase by a group of formula Ia:
wherein R7 comprises a solid phase; R8 is optionally present and comprises a protein, R9 comprises a bond to the compound, and n1 and n2 are each independently an integer between 1 and 5.

### Claim 8 (depends on 1)

The compound according to claim 1, wherein the solid phase comprises heads or microspheres.

### Claim 9

A method for detecting non-transferrin bound iron in a sample, comprising:
a) contacting the sample with a fluorescent iron-binding compound bound to a solid phase; and
b) detecting a fluorescent signal derived from the fluorescent iron-binding compound bound to the solid phase, wherein the fluorescent signal is indicative of non-transferrin bound iron levels in the sample.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the fluorescent signal is detected by flow cytometry.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the method provides a fluorescent signal indicative of non-transferrin bound iron levels at least in the concentration range 0.01 to 1 μM.

### Claim 12 (depends on 9)

A method for monitoring iron overload in a subject, comprising detecting non-transferrin bound iron in a sample from the subject by a method according to claim 9.

### Claim 13 (depends on 1)

A composition comprising a fluorescent iron-binding compound according to claim 1, wherein the composition is suitable to detect non-transferrin bound iron in a sample.

### Claim 14 (depends on 1)

A kit for detecting non-transferrin bound iron in a sample, comprising a fluorescent iron-binding compound according to claim 1, packaged in one or more containers with one or more further reagents.

### Claim 15

A compound according to formula (II):
wherein R1, R2, R3 and R4 are each independently selected from hydrogen, hydroxyl and C1-C5 alkyl, e.g. methyl, provided that at least one of R1 and R4 is hydroxyl;
R5′ comprises a group capable of forming a linkage to a solid phase; and
R6 comprises a fluorophore.

### Claim 16 (depends on 3)

A method for producing the compound of claim 3 comprising reacting a compound of formula (II) with a solid phase, wherein the compound of formula (II) is:
wherein R1, R2, R3 and R4 are each independently selected from hydrogen, hydroxyl and C1-C5 alkyl, e.g. methyl, provided that at least one of R1 and R4 is hydroxyl;
R5′ comprises a group capable of forming a linkage to a solid phase; and
R6 comprises a fluorophore.

### Claim 17 (depends on 1)

The compound according to claim 1, comprising a group of formula VIII:
wherein:
R1, R2 and R4 are each independently selected from hydrogen, hydroxyl and C1-C5 alkyl, e.g. methyl, provided that at least one of R1 and R4 is hydroxyl;
R10 is hydrogen or C1-C5 alkyl, e.g. methyl; and
R11 comprises a fluorophore and a linkage to a solid phase.

### Claim 18 (depends on 17)

The compound according to claim 17, comprising a group of formula IX:
wherein R11 comprises a fluorophore and a linkage to a solid phase.

### Claim 19 (depends on 1)

The compound according to claim 1, comprising a group of formula XI:
wherein:
R1, R2 and R4 are each independently selected from hydrogen, hydroxyl and C1-C5 alkyl, e.g. methyl, provided that at least one of R1 and R4 is hydroxyl; and
R11 comprises a fluorophore and a linkage to a solid phase.

### Claim 20 (depends on 19)

The compound according to claim 19, comprising a group of formula XII:
wherein R11 comprises a fluorophore and a linkage to a solid phase.

### Claim 21 (depends on 17)

The compound according to claim 17, wherein R11 comprises a group of formula X:
wherein R12 comprises a bond to the compound of formula IX or formula XII;
R13 comprises a fluorophore; and
R14 comprises a linkage to a solid phase.

### Claim 22 (depends on 19)

The compound according to claim 19, wherein R11 comprises a group of formula X:
wherein R12 comprises a bond to the compound of formula IX or formula XII;
R13 comprises a fluorophore; and
R14 comprises a linkage to a solid phase.
